Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from Covid-19

‘One million empty chairs’: The US families torn apart by COVID

As nation hits sombre mark of one million coronavirus deaths, families remember loved ones lost during the pandemic.

Al Jazeera

US Postal Service offers more free COVID-19 tests by mail

The U.S. government is offering another round of free at-home COVID-19 test kits to every residential address in the country.

Tribune News Service

As US reaches one million COVID deaths, how are Americans coping?

The torrent of coronavirus deaths, along with prolonged social isolation and financial hardship, have traumatised many.

Al Jazeera

From analysis to the latest developments in health,
read the most diverse news in one place.

Breathing life into medical oxygen

Covid-19 has taken at least 18 million lives by some accounts, and it is anyone's guess how many of those deaths were due to a lack of medical oxygen. Governments don't want to talk about the issue, because that could mean admitting that thousands -- or even hundreds of thousands…

Bangkok Post

VIRI: Enrollment Complete in FORTRESS Trial; Results Expected in September 2022…

By David Bautz, PhD NASDAQ:VIRI READ THE FULL VIRI RESEARCH REPORT

Benzinga

FDA Declines Emergency Use Request For An Antidepressant As COVID-19 Treatment

The FDA has decided not to authorize fluvoxamine, an antidepressant, to treat COVID-19. The agency that data has not shown the drug to be an effective therapeutic for fighting the virus. "Based on the review of available scientific evidence, the FDA has determined that the data are insufficient to conclude that fluvoxamine…

Benzinga

AstraZeneca In-Licenses New Suite Of COVID-19 Antibody Candidate(s)

AstraZeneca plc (NASDAQ:AZN) moved to bolster its COVID-19 portfolio of antibodies with a $157 million licensing deal for experimental therapies developed by newly-launched UK-based biotech, RQ Biotechnology Ltd. In addition to the initial sum, AstraZeneca will pay possible royalty payments as part of the exclusive license to develop pre-clinical COVID antibodies engineered by RQ…

Benzinga

Read news from The Economist, FT, and more,
with one subscription

WPI inflation at 9-year high of 15.1%, 13th month of double-digit rise

NEW DELHI: Wholesale price index (WPI) based inflation jumped to a new high of 15.1% in April on the back of soaring commodity, food and fuel prices, posing a major challenge for authorities already battling surging prices fuelled by the Ukraine war and breakdown in global supply chains due to…

The Times of India

COVID cases among students escalate as two schools extend remote learning

There was a dramatic increase in COVID-19 cases among ACT public schools students last week.

The Canberra Times

South Carolina seeing spike in COVID-19 cases this month

South Carolina has seen a rise in COVID-19 cases this month as tougher variants spread and more people mingle without protection, experts say.

Tribune News Service

Isle of Man medical director faced ‘disgraceful’ bullying, tribunal finds

Dr Rosalind Ranson forced out of job and accused of ‘seeking limelight’ after raising Covid concerns

The Guardian - UK

Hepatitis warning as 12 children die and 400 cases detected amid global outbreak

Parents and guardians are being urged to watch out for the signs and symptoms of hepatitis in children as the global outbreak continues to spread

Chronicle Live

Summer Infant Q1 Sales Drop 5% On Supply Chain Issues

Summer Infant Inc (NASDAQ:SUMR) reported a first-quarter FY22 sales decline of 5% year-on-year to $34.38 million, versus $36.20 million the previous year. The company attributed the revenue decline to ongoing supply chain disruptions, including some COVID-19 caused production delays. The gross profit decreased 31.8% Y/Y to $7.3 million and the profit margin contracted…

Benzinga

Hotel worker sparks debate sharing tip left by guest with Covid

‘$20 is not going to make up for loss of pay when you have to take days off’

The Independent UK

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK

New York City placed on ‘high’ Covid alert amid rising cases

Move came just one day after US death toll from virus hit one million

AAP

Rising COVID-19 cases inevitable: PM

Scott Morrison says rising COVID-19 infection rates were inevitable and Australia's management of the pandemic has been one of the best in the world.

Daily Mirror

Football pitch invasions can only be tolerated as acts of celebration - not ugly chaos

Pitch invasions and supporters with pyrotechnics are on the rise in football as fans have returned from the Covid lockout, but some are taking things too far

Tribune News Service

Eric Clapton catches COVID-19 after calling vaccine efforts a ‘mass psychosis’

Eric Clapton, who has railed against lockdowns and vaccines, has tested positive for COVID-19.

Get all your
news in one place.

100's of premium titles.
One news app.

Newsroom.co.nz

Bosses must change the discriminatory inflexibility of working from home

WFH is mostly great but depends on how well your employer supports you and if they see productivity as just ‘time in the seat’, says Jo Cribb

WEKU

FDA authorizes first COVID booster for children ages 5 to 11

The Food and Drug Administration expanded authorization of Pfizer-BioNTech's COVID vaccine to enable kids ages 5 to 11 who were vaccinated at least five months ago to get a third shot.

Benzinga

Shareholders Rejected Intel's Top Executive Compensation Just A Month After It Painted Dismal Q2 Outlook

Intel Corp (NASDAQ:INTC) shareholders rejected compensation packages for top executives, including a payout of as much as $178.6 million to CEO Pat Gelsinger. Shareholders cast 1.78 billion votes against executive compensation at the annual meeting. Shareholders cast 921.2 million votes in favor of the compensation. The vote is non-binding. Gelsinger has earned 1,711 times as…

Daily Mirror

When will the US lift Covid testing requirements for travellers?

The US government is under pressure to lift all Covid travel restrictions, with hundreds of travel firms issuing a plea to end requirement for pre-departure testing

Benzinga

FDA Gives Nod To First Nonprescription COVID-19 Test That Also Detects Flu, RSV

The FDA has authorized the first nonprescription test to detect Covid-19, influenza, and respiratory syncytial virus (RSV). The test, called the Labcorp Seasonal Respiratory Virus RT-PCR DTC Test, was developed by Laboratory Corp of America Holdings (NYSE:LH). It can be sold directly to consumers online or at retail. A person can self-collect a nasal…

Benzinga

FDA May Authorize Pfizer-BioNTech's COVID-19 Booster For 5-11 Year Kids Soon: NYT

The FDA is expected to authorize a booster shot of Pfizer Inc (NYSE:PFE) / BioNTech SE's (NASDAQ:BNTX) COVID-19 vaccine for children aged 5 to 11 probably by today, the New York Times reported, citing people familiar with the matter. The companies submitted an application to the FDA for authorization last month. They have cited data from…

Irish Mirror

Spain holiday balcony warning as Irish tourists face huge fines for breaking little-known rule

While most Covid travel restrictions have been lifted, there are still many reasons why a trip to Spain could be risky if you're not aware of local laws and customs

1 … 938 939 940 941

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Food and Drug Administration

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.